Claire Anne Ward, NP
Nurse Practitioner · Truckee
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 15 years
- University of Missouri, Columbia School of Medicine, 2011
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location · Tahoe Forest Hospital District · 140 clinicians in this group
Hospitals listed: Tahoe Forest Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Claire Anne Ward’s office at (530) 587-6011 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Tahoe Forest HospitalTruckee, CACritical Access Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Tahoe Forest Hospital District, which runs 2 hospitals in 2 statesPatients rate it 5 of 5 · 90% would definitely recommend itOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Tahoe Forest Hospital
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 1 better, 5 the same, 1 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for heart failure patientsComplications and deaths | 9.4 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.2 · 59 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 293 cases | None | Jul 2024 – Jun 2025 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.8 · 63 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.38 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.4 · 40 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -56.5 · 61 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 12.6 · 64 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.8 (4 to 8.5) · 155 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.5 (7.6 to 14.1) · 155 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 68 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.6) · 65 cases | No different | Jan 2024 – Dec 2024 |
What patients said (278 patients answered, 22% of those asked)
| Cleanliness | 5 |
| Nurse communication | 5 |
| Doctor communication | 5 |
| Communication about medicines | 5 |
| Discharge information | 5 |
| Overall hospital rating | 5 |
| Quietness | 5 |
| Recommend hospital | 5 |
| Room was "always" clean | 86% |
| Nurses "always" communicated well | 90% |
| Doctors "always" communicated well | 88% |
| Staff "always" explained | 76% |
| Yes, staff "did" give patients this information | 93% |
| Yes, staff "did" give patients information about help after discharge | 93% |
| Doctors "always" explained things so they could understand | 82% |
| Doctors "always" listened carefully | 88% |
| Doctors "always" treated them with courtesy and respect | 93% |
| Patients who gave a rating of "9" or "10" (high) | 90% |
| Staff "always" explained new medications | 86% |
| Nurses "always" explained things so they could understand | 86% |
| Nurses "always" listened carefully | 89% |
| Nurses "always" treated them with courtesy and respect | 95% |
| "Always" quiet at night | 72% |
| "YES", patients would definitely recommend the hospital | 90% |
| Staff "always" explained possible side effects | 66% |
| Yes, staff "did" give patients information about possible symptoms | 93% |
Drugs they prescribed that Part D paid
$7,306
Pharmacies billed $7,306 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 53) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
45 generic and fewer than 11 brand-name prescriptions · $7,306 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 18 | $3,798 | $123 |
Year by year
| 2024 | 53 | 23 | 0% (0) | None | $7,306 |
| 2023 | 28 | None | 0% (0) | None | $3,347 |
| 2022 | 18 | 11 | 0% (0) | None | $2,484 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$84 in 2025
| 2025 | 3 | 4 | None | $84 |
| 2024 | 1 | 1 | None | $32 |
| 2023 | 1 | 1 | None | $19 |
| 2022 | 1 | 1 | None | $29 |
| 2021 | 1 | 1 | None | $23 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Astellas Pharma US | Veozah | $40 | 2 payments
|
| Sage Therapeutics | Zurzuvae | $22 | 1 payment
|
| Supernus Pharmaceuticals | Qelbree | $22 | 1 payment
|
See all 4 published payments
| Sage Therapeutics | Meals · 2025-11-04 | Zurzuvae | $22 |
| Supernus Pharmaceuticals | Meals · 2025-11-04 | Qelbree | $22 |
| Astellas Pharma US | Meals · 2025-09-25 | Veozah | $18 |
| Astellas Pharma US | Meals · 2025-08-28 | Veozah | $23 |
See earlier years (2024, 2023, 2022, 2021)
2024: $32
| Sage Therapeutics | Zurzuvae | $32 | 1 payment
|
2023: $19
| Sumitomo Pharma America | Myfembree | $19 | 1 payment
|
2022: $29
| Abbvie | Oriahnn | $29 | 1 payment
|
2021: $23
| TherapeuticsMD | Annovera | $23 | 1 payment
|
Professional record
- NPI
- 1285908947
- Licence
- CA 95008723, HI APRN-1843
- Trained
- University of Missouri, Columbia School of Medicine, 2011 · 15 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X); Federal specialty code 363LW0102X (363LW0102X)
- Mailing address
- 725 Welch Rd, Palo Alto, CA, 94304
- NPI first listed
- 2012-02-28
- NPI last updated
- 2018-08-20
This is when the NPI record was last certified, not a medical board exam.